BMRA
Income statement / Annual
Last year (2024), Biomerica, Inc.'s total revenue was $5.42 M,
an increase of 1.42% from the previous year.
In 2024, Biomerica, Inc.'s net income was -$5.98 M.
See Biomerica, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
05/31/2024 |
05/31/2023 |
05/31/2022 |
05/31/2021 |
05/31/2020 |
05/31/2019 |
05/31/2018 |
05/31/2017 |
05/31/2016 |
05/31/2015 |
Operating Revenue |
$5.42 M |
$5.34 M |
$18.87 M |
$7.20 M |
$6.69 M |
$5.20 M |
$5.56 M |
$5.79 M |
$5.14 M |
$4.96 M |
Cost of Revenue |
$4.80 M
|
$4.89 M
|
$15.89 M
|
$6.70 M
|
$4.91 M
|
$3.91 M
|
$3.81 M
|
$3.77 M
|
$3.62 M
|
$3.42 M
|
Gross Profit |
$611,000.00
|
$446,000.00
|
$2.98 M
|
$496,981.00
|
$1.78 M
|
$1.29 M
|
$1.75 M
|
$2.02 M
|
$1.52 M
|
$1.54 M
|
Gross Profit Ratio |
0.11
|
0.08
|
0.16
|
0.07
|
0.27
|
0.25
|
0.32
|
0.35
|
0.3
|
0.31
|
Research and Development Expenses |
$1.49 M
|
$1.58 M
|
$1.81 M
|
$2.41 M
|
$1.91 M
|
$1.68 M
|
$1.40 M
|
$1.13 M
|
$780,333.00
|
$733,640.00
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14,613.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1,223.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$5.49 M
|
$6.09 M
|
$5.70 M
|
$4.61 M
|
$2.27 M
|
$2.03 M
|
$1.84 M
|
$1.85 M
|
$1.57 M
|
$1.48 M
|
Other Expenses |
$0.00
|
$1,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7,009.00
|
$2,255.00
|
Operating Expenses |
$6.98 M
|
$7.67 M
|
$7.51 M
|
$7.02 M
|
$4.18 M
|
$3.70 M
|
$3.24 M
|
$2.98 M
|
$2.35 M
|
$2.21 M
|
Cost And Expenses |
$11.78 M
|
$12.56 M
|
$23.41 M
|
$13.72 M
|
$9.10 M
|
$7.61 M
|
$7.05 M
|
$6.75 M
|
$5.97 M
|
$5.63 M
|
Interest Income |
$431,000.00
|
$133,000.00
|
$26,639.00
|
$66,863.00
|
$71,193.00
|
$44,014.00
|
$47,764.00
|
$46,354.00
|
$24,123.00
|
$21,906.00
|
Interest Expense |
$0.00
|
$0.00
|
$26,639.00
|
$367.00
|
$9.00
|
$47.00
|
$37.00
|
$282.00
|
$167.00
|
$0.00
|
Depreciation & Amortization |
$374,000.00
|
$351,000.00
|
$594,821.00
|
$375,855.00
|
$398,632.00
|
$162,905.00
|
$186,601.00
|
$219,219.00
|
$232,422.00
|
$253,275.00
|
EBITDA |
-$5.99 M |
-$6.74 M |
-$3.94 M |
-$7.06 M |
-$2.27 M |
-$2.21 M |
-$1.25 M |
-$689,340.00 |
-$563,567.00 |
-$393,154.00 |
EBITDA Ratio |
-1.11
|
-1.29
|
-0.21
|
-0.84
|
-0.29
|
-0.42
|
-0.22
|
-0.12
|
-0.11
|
-0.08
|
Operating Income Ratio |
-1.18
|
-1.35
|
-0.24
|
-0.91
|
-0.36
|
-0.46
|
-0.27
|
-0.16
|
-0.16
|
-0.14
|
Total Other Income/Expenses Net |
$431,000.00
|
$134,000.00
|
$26,639.00
|
$66,496.00
|
$71,184.00
|
$43,967.00
|
$47,727.00
|
$46,072.00
|
$30,965.00
|
$24,161.00
|
Income Before Tax |
-$5.94 M
|
-$7.09 M
|
-$4.51 M
|
-$6.46 M
|
-$2.33 M
|
-$2.37 M
|
-$1.43 M
|
-$908,561.00
|
-$795,987.00
|
-$646,434.00
|
Income Before Tax Ratio |
-1.1
|
-1.33
|
-0.24
|
-0.9
|
-0.35
|
-0.46
|
-0.26
|
-0.16
|
-0.15
|
-0.13
|
Income Tax Expense |
$42,000.00
|
$51,000.00
|
$23,719.00
|
$13,057.00
|
$7,390.00
|
$24,237.00
|
$31,800.00
|
$46,636.00
|
$703,800.00
|
-$315,024.00
|
Net Income |
-$5.98 M
|
-$7.14 M
|
-$4.53 M
|
-$6.47 M
|
-$2.34 M
|
-$2.39 M
|
-$1.47 M
|
-$908,561.00
|
-$1.50 M
|
-$331,410.00
|
Net Income Ratio |
-1.1
|
-1.34
|
-0.24
|
-0.9
|
-0.35
|
-0.46
|
-0.26
|
-0.16
|
-0.29
|
-0.07
|
EPS |
-0.36 |
-0.5 |
-0.36 |
-0.54 |
-0.23 |
-0.26 |
-0.17 |
-0.11 |
-0.2 |
-0.0439 |
EPS Diluted |
-0.36 |
-0.5 |
-0.36 |
-0.54 |
-0.23 |
-0.26 |
-0.17 |
-0.11 |
-0.2 |
-0.0439 |
Weighted Average Shares Out |
$16.82 M
|
$14.15 M
|
$12.67 M
|
$11.93 M
|
$10.17 M
|
$9.21 M
|
$8.57 M
|
$8.26 M
|
$7.50 M
|
$7.55 M
|
Weighted Average Shares Out Diluted |
$16.82 M
|
$14.15 M
|
$12.67 M
|
$11.93 M
|
$10.17 M
|
$9.21 M
|
$8.57 M
|
$8.33 M
|
$7.63 M
|
$7.55 M
|
Link |
|
|
|
|
|
|
|
|
|
|